Live Quote · NASDAQCTMXHealthcare· Biotechnology

CytomX Therapeutics, Inc.

$2.03▼ 0.98%($-0.02)
MKT CAP $442.55MNEXT EARNINGS Feb 24, 2027
50%
Bullish
TickerSpark Score
44/100
▌ Weak
60
Valuation
40
Profitability
10
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTMX research report →

Analyst Price Target
$6.00+195.6% vs. today

Range $6 – $6

Analyst RatingBuy
17 Buy4 Hold0 Sell

Price Chart

-46.15% · this period
$6.75$4.31$1.88Nov 20May 26Nov 20
52-Week Range3% of range
Low
$1.87
Current
$2.03
High
$8.21